Dendritic Cell-Based Therapeutic Immunization Induces Th1/Th17 Responses and Reduces Fungal Burden in Experimental Sporotrichosis
mycolabadmin
Researchers developed a vaccine using special immune cells called dendritic cells loaded with proteins from the fungus that causes sporotrichosis. When vaccinated mice were later infected with the fungus, they showed stronger immune responses and had lower levels of the fungus in their bodies. This suggests that dendritic cell-based vaccines could be a promising new treatment approach for sporotrichosis, a serious fungal infection that is difficult to treat with current medicines, especially in people with weakened immune systems.